Management of Chronic Hepatitis B in the HIV-Infected Patient

Research output: Contribution to journalArticle

Abstract

Coinfection with HIV and hepatitis B virus (HBV) is common because of their shared modes of transmission. HIV infection alters the natural history of HBV infection, leading to more severe liver disease, decreased hepatitis B e antigen seroconversion, and higher HBV DNA levels. Furthermore, end-stage liver disease has emerged as a common cause of morbidity and mortality in HIV-infected persons receiving HAART. For these reasons, it is important to vaccinate susceptible persons against HBV infection and to diagnose and treat chronic hepatitis B in HIV-infected persons. The treatment plan for chronic hepatitis B needs to be individualized based on the stage of both viral infections and the available options. It is anticipated that we are entering the period of combination therapy for chronic hepatitis B, but the ideal combination needs to be elucidated.

Original languageEnglish (US)
Pages (from-to)122-129+133+136
JournalThe AIDS reader
Volume14
Issue number3
StatePublished - Mar 2004

Fingerprint

Chronic Hepatitis B
Hepatitis B virus
Virus Diseases
HIV
End Stage Liver Disease
Hepatitis B e Antigens
Highly Active Antiretroviral Therapy
Natural History
Coinfection
HIV Infections
Liver Diseases
Morbidity
Mortality
DNA
Therapeutics

Keywords

  • Coinfection
  • Hepatitis B virus
  • Hepatitis B, chronic
  • HIV/AIDS

ASJC Scopus subject areas

  • Virology
  • Medicine(all)

Cite this

Management of Chronic Hepatitis B in the HIV-Infected Patient. / Thio, Chloe L.

In: The AIDS reader, Vol. 14, No. 3, 03.2004, p. 122-129+133+136.

Research output: Contribution to journalArticle

@article{70210ccd85354fef9351ce415c573a32,
title = "Management of Chronic Hepatitis B in the HIV-Infected Patient",
abstract = "Coinfection with HIV and hepatitis B virus (HBV) is common because of their shared modes of transmission. HIV infection alters the natural history of HBV infection, leading to more severe liver disease, decreased hepatitis B e antigen seroconversion, and higher HBV DNA levels. Furthermore, end-stage liver disease has emerged as a common cause of morbidity and mortality in HIV-infected persons receiving HAART. For these reasons, it is important to vaccinate susceptible persons against HBV infection and to diagnose and treat chronic hepatitis B in HIV-infected persons. The treatment plan for chronic hepatitis B needs to be individualized based on the stage of both viral infections and the available options. It is anticipated that we are entering the period of combination therapy for chronic hepatitis B, but the ideal combination needs to be elucidated.",
keywords = "Coinfection, Hepatitis B virus, Hepatitis B, chronic, HIV/AIDS",
author = "Thio, {Chloe L}",
year = "2004",
month = "3",
language = "English (US)",
volume = "14",
pages = "122--129+133+136",
journal = "AIDS Reader",
issn = "1053-0894",
publisher = "CMP Healthcare Media LLC",
number = "3",

}

TY - JOUR

T1 - Management of Chronic Hepatitis B in the HIV-Infected Patient

AU - Thio, Chloe L

PY - 2004/3

Y1 - 2004/3

N2 - Coinfection with HIV and hepatitis B virus (HBV) is common because of their shared modes of transmission. HIV infection alters the natural history of HBV infection, leading to more severe liver disease, decreased hepatitis B e antigen seroconversion, and higher HBV DNA levels. Furthermore, end-stage liver disease has emerged as a common cause of morbidity and mortality in HIV-infected persons receiving HAART. For these reasons, it is important to vaccinate susceptible persons against HBV infection and to diagnose and treat chronic hepatitis B in HIV-infected persons. The treatment plan for chronic hepatitis B needs to be individualized based on the stage of both viral infections and the available options. It is anticipated that we are entering the period of combination therapy for chronic hepatitis B, but the ideal combination needs to be elucidated.

AB - Coinfection with HIV and hepatitis B virus (HBV) is common because of their shared modes of transmission. HIV infection alters the natural history of HBV infection, leading to more severe liver disease, decreased hepatitis B e antigen seroconversion, and higher HBV DNA levels. Furthermore, end-stage liver disease has emerged as a common cause of morbidity and mortality in HIV-infected persons receiving HAART. For these reasons, it is important to vaccinate susceptible persons against HBV infection and to diagnose and treat chronic hepatitis B in HIV-infected persons. The treatment plan for chronic hepatitis B needs to be individualized based on the stage of both viral infections and the available options. It is anticipated that we are entering the period of combination therapy for chronic hepatitis B, but the ideal combination needs to be elucidated.

KW - Coinfection

KW - Hepatitis B virus

KW - Hepatitis B, chronic

KW - HIV/AIDS

UR - http://www.scopus.com/inward/record.url?scp=1542615142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542615142&partnerID=8YFLogxK

M3 - Article

C2 - 15068000

AN - SCOPUS:1542615142

VL - 14

SP - 122-129+133+136

JO - AIDS Reader

JF - AIDS Reader

SN - 1053-0894

IS - 3

ER -